Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01083147 · ClinicalTrials.gov registry record
Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment
A clinical trial, sponsored by Notal Vision.
- Completed
- Registry status
- 50
- Enrollment target
NCT01083147 is a clinical trial that has completed, run by Notal Vision. The registered enrollment target is 50 participants.
The verdict
NCT01083147 has completed, sponsored by Notal Vision.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.
Interventions
- DEVICE FORESEE HOME
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01083147
The ClinicalTrials.gov registry entry for NCT01083147 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Notal Vision, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FORESEE HOME is the first listed.
NCT01083147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01083147 about?
NCT01083147 is a clinical study titled "Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment". The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.
What is the current status of trial NCT01083147?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2009-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01083147?
The interventions under investigation include: FORESEE HOME (DEVICE).
Who is sponsoring clinical trial NCT01083147?
This trial is sponsored by Notal Vision, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.